PubMed · 16444352
[Differentiated thyroid carcinoma: initial evaluation and follow-up].
Abstract
Thyroid carcinoma accounts for roughly 1% of all new malignant diseases. Of these, at least 94% are differentiated thyroid carcinoma (DTC), either papillary thyroid carcinoma or follicular thyroid carcinoma. Patients with DTC are usually considered as having a good prognosis, 80% of patients are cured, 20% will develop loco-regional recurrence and 5-10% distant metastasis. However, the disease may have an aggressive course in some patients. The identification of these patients has a major impact in the clinical management of DTC. Several prognostic factors and classification will be addressed, as well the most useful tests for patients follow-up.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Lenara Golbert, Simone Magagnin Wajner, Andreia Possatti da Rocha, Ana Luiza Maia, Jorge Luiz Gross. 2006-01-23. [Differentiated thyroid carcinoma: initial evaluation and follow-up].. https://doi.org/10.1590/s0004-27302005000500010
Cite the original work for its findings. Save a collection to share your selection of sources.